Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 20, 2015
0Patent Application Number
132993100
Date Filed
November 17, 2011
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Oligonucleotide analogues conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.